Followers | 145 |
Posts | 27566 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Thursday, December 17, 2020 9:58:40 AM
Dec. 17, 2020 9:52 AM ETGamida Cell Ltd. (GMDA)By: Shweta Agarwal, SA News Editor
Gamida Cell (GMDA +4.6%) prices public offering of 8,125,000 common shares at a price of $8/share.
Underwriters' have been granted overallotment option to purchase up to an additional 1,218,750 shares.
The company intends to use the net proceeds to fund (i) the preparation of a potential commercial launch of omidubicel; (ii) the continued clinical development of its product candidates, including GDA-201; (iii) the expansion of its commercial manufacturing capabilities; and (iv) general corporate purposes.
The offering is expected to close on Dec. 21, 2020.
Recent GMDAQ News
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/10/2024 08:19:25 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 05/09/2024 08:08:28 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 05/09/2024 08:04:39 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM